Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Increasing Amyloidosis Awareness and Diagnosis Through Programmatic Imaging, Blood/Urine Testing and Pathology

NCT04983433 is registered in ClinicalTrials.gov with Beneficência Portuguesa de São Paulo as lead sponsor.

NCT NCT04983433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04983433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Increasing Amyloidosis Awareness and Diagnosis Through Programmatic Imaging, Blood/Urine Testing and Pathology
Lead sponsor
Beneficência Portuguesa de São Paulo
Phase
Observational
Overall status
Unknown status
Start date
August 5, 2021
Completion date
August 31, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis